Klingenstein Fields & Co. LP Has $221,000 Position in CVS Health Co. (NYSE:CVS)

Klingenstein Fields & Co. LP reduced its holdings in shares of CVS Health Co. (NYSE:CVS) by 4.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 4,918 shares of the pharmacy operator’s stock after selling 223 shares during the quarter. Klingenstein Fields & Co. LP’s holdings in CVS Health were worth $221,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the 3rd quarter worth about $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health during the 3rd quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health during the 3rd quarter worth about $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health during the 3rd quarter worth about $32,000. Finally, Ridgewood Investments LLC boosted its position in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS Health stock opened at $66.35 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $83.49 billion, a PE ratio of 16.84, a P/E/G ratio of 0.60 and a beta of 0.61. The firm has a fifty day simple moving average of $50.71 and a two-hundred day simple moving average of $55.94. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. Research analysts expect that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on CVS shares. Piper Sandler cut their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Barclays increased their price objective on shares of CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday. Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and raised their price target for the company from $55.00 to $75.00 in a research report on Thursday. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, Royal Bank of Canada dropped their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Five analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $70.28.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.